-
. Application process is opened worldwide (visa restrictions may apply). French candidates residing and working outside Clermont-Ferrand are eligible. Peptide radionuclide therapy (PRT) face a growing interest
-
targets. Main activities: - Bioinformatic analysis of WES and RNA-seq data. - Variant calling, annotation, and mutational signature analysis. - Differential gene expression and pathway analyses
-
at the proteome scale using innovative biophysical and interactomic approaches, including the native holdup assay. Main responsibilities -Cloning plasmids for recombinant protein expression. -Producing and
-
analysis) approaches. Responsibilities: Under the supervision of Dr. Nicolas Marie (a CNRS researcher), the postdoctoral fellow will: Modulate SEZ6 expression in vivo (AAV, shRNA) and assess its impact on
-
conducted within a consortium of laboratories based in Paris. Mission The successful candidate will design, conduct, and coordinate complex experimental work, including optimization of gene expression tools
-
nanoparticles) nano-objects for the delivery of personalized therapies for difficult-to-treat diseases. Another aspect of NABI is to develop innovative physics-based therapies such as nanohyperthermia or cold